nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CASP9—NOD1/2 Signaling Pathway—CARD9—ankylosing spondylitis	0.0297	0.0527	CbGpPWpGaD
Hydroxocobalamin—CASP9—NOD pathway—CARD9—ankylosing spondylitis	0.0237	0.0421	CbGpPWpGaD
Hydroxocobalamin—CASP9—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.0202	0.0359	CbGpPWpGaD
Hydroxocobalamin—MMAB—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.0178	0.0316	CbGpPWpGaD
Hydroxocobalamin—TCN1—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.0178	0.0316	CbGpPWpGaD
Hydroxocobalamin—TCN2—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.0165	0.0294	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—IL1R2—ankylosing spondylitis	0.0145	0.0257	CbGpPWpGaD
Hydroxocobalamin—MUT—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.0141	0.025	CbGpPWpGaD
Hydroxocobalamin—CUBN—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.013	0.023	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.0107	0.0189	CbGpPWpGaD
Hydroxocobalamin—CASP9—FAS pathway and Stress induction of HSP regulation—IL1A—ankylosing spondylitis	0.00913	0.0162	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.00885	0.0157	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-C—ankylosing spondylitis	0.00881	0.0156	CbGpPWpGaD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00868	0.0154	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—CRP—ankylosing spondylitis	0.00867	0.0154	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.00861	0.0153	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.00808	0.0143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL17A—ankylosing spondylitis	0.00806	0.0143	CbGpPWpGaD
Hydroxocobalamin—TCN1—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00805	0.0143	CbGpPWpGaD
Hydroxocobalamin—MMAB—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00805	0.0143	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.00801	0.0142	CbGpPWpGaD
Hydroxocobalamin—Folliculitis—Triamcinolone—ankylosing spondylitis	0.00798	0.0183	CcSEcCtD
Hydroxocobalamin—Folliculitis—Methylprednisolone—ankylosing spondylitis	0.00796	0.0182	CcSEcCtD
Hydroxocobalamin—CASP9—Allograft Rejection—IL12B—ankylosing spondylitis	0.00749	0.0133	CbGpPWpGaD
Hydroxocobalamin—TCN2—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00748	0.0133	CbGpPWpGaD
Hydroxocobalamin—Folliculitis—Betamethasone—ankylosing spondylitis	0.00724	0.0166	CcSEcCtD
Hydroxocobalamin—Folliculitis—Dexamethasone—ankylosing spondylitis	0.00724	0.0166	CcSEcCtD
Hydroxocobalamin—MTR—Folate Metabolism—CRP—ankylosing spondylitis	0.00706	0.0125	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—ANTXR2—ankylosing spondylitis	0.0066	0.0117	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.00649	0.0115	CbGpPWpGaD
Hydroxocobalamin—MUT—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00636	0.0113	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—ANTXR2—ankylosing spondylitis	0.00603	0.0107	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—ANTXR2—ankylosing spondylitis	0.00603	0.0107	CbGpPWpGaD
Hydroxocobalamin—CUBN—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00587	0.0104	CbGpPWpGaD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.00561	0.00997	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—ANTXR2—ankylosing spondylitis	0.00561	0.00996	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL1A—ankylosing spondylitis	0.00551	0.00978	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL10—ankylosing spondylitis	0.00548	0.00973	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—CD40LG—ankylosing spondylitis	0.00548	0.00973	CbGpPWpGaD
Hydroxocobalamin—Folliculitis—Methotrexate—ankylosing spondylitis	0.00527	0.0121	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00523	0.00928	CbGpPWpGaD
Hydroxocobalamin—Extravasation—Dexamethasone—ankylosing spondylitis	0.00522	0.0119	CcSEcCtD
Hydroxocobalamin—Extravasation—Betamethasone—ankylosing spondylitis	0.00522	0.0119	CcSEcCtD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-B—ankylosing spondylitis	0.00521	0.00925	CbGpPWpGaD
Hydroxocobalamin—Memory impairment—Prednisone—ankylosing spondylitis	0.00505	0.0116	CcSEcCtD
Hydroxocobalamin—AMN—Disease—ANTXR2—ankylosing spondylitis	0.005	0.00888	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ANTXR2—ankylosing spondylitis	0.005	0.00888	CbGpPWpGaD
Hydroxocobalamin—Pulmonary oedema—Prednisolone—ankylosing spondylitis	0.00486	0.0111	CcSEcCtD
Hydroxocobalamin—CASP9—Allograft Rejection—HLA-A—ankylosing spondylitis	0.00483	0.00857	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00482	0.00856	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ANTXR2—ankylosing spondylitis	0.00477	0.00847	CbGpPWpGaD
Hydroxocobalamin—Lung disorder—Methotrexate—ankylosing spondylitis	0.00468	0.0107	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00462	0.00821	CbGpPWpGaD
Hydroxocobalamin—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.00447	0.0102	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.00446	0.0102	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—ANTXR2—ankylosing spondylitis	0.0044	0.00782	CbGpPWpGaD
Hydroxocobalamin—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.00437	0.01	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Methotrexate—ankylosing spondylitis	0.00433	0.0099	CcSEcCtD
Hydroxocobalamin—CASP9—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	0.00419	0.00744	CbGpPWpGaD
Hydroxocobalamin—Dermatitis bullous—Prednisolone—ankylosing spondylitis	0.00414	0.00948	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.00405	0.00927	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.00405	0.00927	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.00402	0.00919	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.00401	0.00917	CcSEcCtD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00393	0.00698	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—TNF—ankylosing spondylitis	0.00392	0.00697	CbGpPWpGaD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.00391	0.00694	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—B3GNT2—ankylosing spondylitis	0.00389	0.0069	CbGpPWpGaD
Hydroxocobalamin—Dermatitis bullous—Triamcinolone—ankylosing spondylitis	0.00381	0.00872	CcSEcCtD
Hydroxocobalamin—Extravasation—Methotrexate—ankylosing spondylitis	0.0038	0.00869	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00377	0.00862	CcSEcCtD
Hydroxocobalamin—CASP9—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.00374	0.00665	CbGpPWpGaD
Hydroxocobalamin—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.00364	0.00834	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.00364	0.00834	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—ANTXR2—ankylosing spondylitis	0.00361	0.00642	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—B3GNT2—ankylosing spondylitis	0.00356	0.00631	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—B3GNT2—ankylosing spondylitis	0.00356	0.00631	CbGpPWpGaD
Hydroxocobalamin—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.00353	0.00808	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00346	0.00793	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.00346	0.00791	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.00346	0.00791	CcSEcCtD
Hydroxocobalamin—CASP9—FAS pathway and Stress induction of HSP regulation—TNF—ankylosing spondylitis	0.00346	0.00614	CbGpPWpGaD
Hydroxocobalamin—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00345	0.00791	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—B3GNT2—ankylosing spondylitis	0.00331	0.00587	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—CD79A—ankylosing spondylitis	0.00326	0.00579	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—B3GNT2—ankylosing spondylitis	0.00326	0.00578	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—TNF—ankylosing spondylitis	0.0032	0.00568	CbGpPWpGaD
Hydroxocobalamin—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.00317	0.00726	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—KIR3DL1—ankylosing spondylitis	0.00317	0.00563	CbGpPWpGaD
Hydroxocobalamin—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00314	0.00719	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00314	0.00719	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.00301	0.00535	CbGpPWpGaD
Hydroxocobalamin—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00301	0.00688	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00301	0.00688	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.003	0.00533	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—B3GNT2—ankylosing spondylitis	0.00298	0.00529	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—B3GNT2—ankylosing spondylitis	0.00298	0.00529	CbGpPWpGaD
Hydroxocobalamin—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.00295	0.00675	CcSEcCtD
Hydroxocobalamin—MMAA—Disease—B3GNT2—ankylosing spondylitis	0.00295	0.00523	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—B3GNT2—ankylosing spondylitis	0.00295	0.00523	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ANTXR2—ankylosing spondylitis	0.00295	0.00523	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CARD9—ankylosing spondylitis	0.00286	0.00508	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—B3GNT2—ankylosing spondylitis	0.00281	0.00499	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—B3GNT2—ankylosing spondylitis	0.00277	0.00492	CbGpPWpGaD
Hydroxocobalamin—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00274	0.00626	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00273	0.00485	CbGpPWpGaD
Hydroxocobalamin—CASP9—Caspase Cascade in Apoptosis—TNF—ankylosing spondylitis	0.00271	0.00481	CbGpPWpGaD
Hydroxocobalamin—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00262	0.00599	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—B3GNT2—ankylosing spondylitis	0.00259	0.00461	CbGpPWpGaD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.00254	0.00451	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—B3GNT2—ankylosing spondylitis	0.00247	0.00438	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—B3GNT2—ankylosing spondylitis	0.00247	0.00438	CbGpPWpGaD
Hydroxocobalamin—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00245	0.0056	CcSEcCtD
Hydroxocobalamin—Erythema—Prednisolone—ankylosing spondylitis	0.00238	0.00546	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—B3GNT2—ankylosing spondylitis	0.00235	0.00418	CbGpPWpGaD
Hydroxocobalamin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00235	0.00538	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00233	0.00534	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00228	0.00522	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00227	0.0052	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00227	0.00519	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00225	0.00515	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00225	0.00514	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—ANTXR2—ankylosing spondylitis	0.00222	0.00394	CbGpPWpGaD
Hydroxocobalamin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00221	0.00507	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.0022	0.00504	CcSEcCtD
Hydroxocobalamin—Erythema—Triamcinolone—ankylosing spondylitis	0.00219	0.00502	CcSEcCtD
Hydroxocobalamin—Erythema—Methylprednisolone—ankylosing spondylitis	0.00219	0.00501	CcSEcCtD
Hydroxocobalamin—Angioedema—Prednisolone—ankylosing spondylitis	0.00218	0.00499	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—B3GNT2—ankylosing spondylitis	0.00217	0.00386	CbGpPWpGaD
Hydroxocobalamin—Malaise—Prednisolone—ankylosing spondylitis	0.00215	0.00492	CcSEcCtD
Hydroxocobalamin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00214	0.00489	CcSEcCtD
Hydroxocobalamin—Eye disorder—Betamethasone—ankylosing spondylitis	0.00214	0.00489	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—B3GNT2—ankylosing spondylitis	0.00213	0.00378	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—TNF—ankylosing spondylitis	0.00209	0.0037	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—TNF—ankylosing spondylitis	0.00209	0.0037	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00207	0.00475	CcSEcCtD
Hydroxocobalamin—Angiopathy—Betamethasone—ankylosing spondylitis	0.00207	0.00475	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00204	0.00467	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00204	0.00467	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00203	0.00466	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00203	0.00465	CcSEcCtD
Hydroxocobalamin—Discomfort—Prednisolone—ankylosing spondylitis	0.00201	0.00459	CcSEcCtD
Hydroxocobalamin—Angioedema—Triamcinolone—ankylosing spondylitis	0.002	0.00459	CcSEcCtD
Hydroxocobalamin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.002	0.00458	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00199	0.00456	CcSEcCtD
Hydroxocobalamin—Erythema—Betamethasone—ankylosing spondylitis	0.00199	0.00456	CcSEcCtD
Hydroxocobalamin—Erythema—Dexamethasone—ankylosing spondylitis	0.00199	0.00456	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—TNF—ankylosing spondylitis	0.00199	0.00353	CbGpPWpGaD
Hydroxocobalamin—Malaise—Triamcinolone—ankylosing spondylitis	0.00198	0.00453	CcSEcCtD
Hydroxocobalamin—Malaise—Methylprednisolone—ankylosing spondylitis	0.00197	0.00452	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00195	0.00446	CcSEcCtD
Hydroxocobalamin—Oedema—Prednisolone—ankylosing spondylitis	0.00195	0.00446	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—IL1R2—ankylosing spondylitis	0.00192	0.00341	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Prednisolone—ankylosing spondylitis	0.0019	0.00435	CcSEcCtD
Hydroxocobalamin—Eye disorder—Prednisone—ankylosing spondylitis	0.00186	0.00426	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00185	0.00424	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00185	0.00423	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00185	0.00423	CcSEcCtD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.00185	0.00328	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Triamcinolone—ankylosing spondylitis	0.00184	0.00422	CcSEcCtD
Hydroxocobalamin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00184	0.00421	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—ERAP1—ankylosing spondylitis	0.00182	0.00323	CbGpPWpGaD
Hydroxocobalamin—Angioedema—Dexamethasone—ankylosing spondylitis	0.00182	0.00416	CcSEcCtD
Hydroxocobalamin—Angioedema—Betamethasone—ankylosing spondylitis	0.00182	0.00416	CcSEcCtD
Hydroxocobalamin—Angiopathy—Prednisone—ankylosing spondylitis	0.00181	0.00413	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Prednisone—ankylosing spondylitis	0.0018	0.00412	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—HLA-C—ankylosing spondylitis	0.0018	0.00319	CbGpPWpGaD
Hydroxocobalamin—Malaise—Betamethasone—ankylosing spondylitis	0.00179	0.00411	CcSEcCtD
Hydroxocobalamin—Malaise—Dexamethasone—ankylosing spondylitis	0.00179	0.00411	CcSEcCtD
Hydroxocobalamin—Oedema—Triamcinolone—ankylosing spondylitis	0.00179	0.0041	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00179	0.0041	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00179	0.00409	CcSEcCtD
Hydroxocobalamin—MTRR—Metabolism—B3GNT2—ankylosing spondylitis	0.00178	0.00317	CbGpPWpGaD
Hydroxocobalamin—Arrhythmia—Prednisone—ankylosing spondylitis	0.00178	0.00407	CcSEcCtD
Hydroxocobalamin—Infection—Triamcinolone—ankylosing spondylitis	0.00178	0.00407	CcSEcCtD
Hydroxocobalamin—Infection—Methylprednisolone—ankylosing spondylitis	0.00177	0.00406	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00175	0.00401	CcSEcCtD
Hydroxocobalamin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00175	0.004	CcSEcCtD
Hydroxocobalamin—Mental disorder—Prednisone—ankylosing spondylitis	0.00174	0.00399	CcSEcCtD
Hydroxocobalamin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00174	0.00399	CcSEcCtD
Hydroxocobalamin—MTR—Disease—B3GNT2—ankylosing spondylitis	0.00174	0.00308	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00173	0.00397	CcSEcCtD
Hydroxocobalamin—Erythema—Prednisone—ankylosing spondylitis	0.00173	0.00397	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00172	0.00306	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Dexamethasone—ankylosing spondylitis	0.00167	0.00383	CcSEcCtD
Hydroxocobalamin—Discomfort—Betamethasone—ankylosing spondylitis	0.00167	0.00383	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—CARD9—ankylosing spondylitis	0.00167	0.00296	CbGpPWpGaD
Hydroxocobalamin—Pain—Prednisolone—ankylosing spondylitis	0.00166	0.00381	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00164	0.00376	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00163	0.00373	CcSEcCtD
Hydroxocobalamin—Oedema—Betamethasone—ankylosing spondylitis	0.00162	0.00372	CcSEcCtD
Hydroxocobalamin—Oedema—Dexamethasone—ankylosing spondylitis	0.00162	0.00372	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00162	0.00372	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00162	0.00372	CcSEcCtD
Hydroxocobalamin—Infection—Betamethasone—ankylosing spondylitis	0.00161	0.00369	CcSEcCtD
Hydroxocobalamin—Infection—Dexamethasone—ankylosing spondylitis	0.00161	0.00369	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00161	0.00368	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0016	0.00367	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.0016	0.00365	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00159	0.00365	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00159	0.00365	CcSEcCtD
Hydroxocobalamin—Agitation—Prednisone—ankylosing spondylitis	0.00159	0.00365	CcSEcCtD
Hydroxocobalamin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00158	0.00363	CcSEcCtD
Hydroxocobalamin—Tachycardia—Betamethasone—ankylosing spondylitis	0.00158	0.00363	CcSEcCtD
Hydroxocobalamin—Angioedema—Prednisone—ankylosing spondylitis	0.00158	0.00362	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00158	0.00361	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—HLA-A—ankylosing spondylitis	0.00157	0.00279	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00157	0.0036	CcSEcCtD
Hydroxocobalamin—Malaise—Prednisone—ankylosing spondylitis	0.00156	0.00358	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—ankylosing spondylitis	0.00155	0.00356	CcSEcCtD
Hydroxocobalamin—Urticaria—Prednisolone—ankylosing spondylitis	0.00155	0.00354	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00154	0.00353	CcSEcCtD
Hydroxocobalamin—Pain—Triamcinolone—ankylosing spondylitis	0.00153	0.0035	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—ankylosing spondylitis	0.00151	0.00346	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.0015	0.00344	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.0015	0.00343	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—ankylosing spondylitis	0.00149	0.00342	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00147	0.00338	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00147	0.00337	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00147	0.00335	CcSEcCtD
Hydroxocobalamin—Discomfort—Prednisone—ankylosing spondylitis	0.00146	0.00334	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—ankylosing spondylitis	0.00146	0.00334	CcSEcCtD
Hydroxocobalamin—MTR—Metabolism—B3GNT2—ankylosing spondylitis	0.00145	0.00258	CbGpPWpGaD
Hydroxocobalamin—Erythema—Methotrexate—ankylosing spondylitis	0.00145	0.00332	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—HLA-A—ankylosing spondylitis	0.00144	0.00256	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HLA-A—ankylosing spondylitis	0.00144	0.00256	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00143	0.00328	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00143	0.00327	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00143	0.00327	CcSEcCtD
Hydroxocobalamin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00142	0.00325	CcSEcCtD
Hydroxocobalamin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00142	0.00325	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00141	0.00324	CcSEcCtD
Hydroxocobalamin—Oedema—Prednisone—ankylosing spondylitis	0.00141	0.00324	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00141	0.00324	CcSEcCtD
Hydroxocobalamin—Infection—Prednisone—ankylosing spondylitis	0.00141	0.00322	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.0014	0.00321	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.0014	0.00321	CcSEcCtD
Hydroxocobalamin—Pain—Betamethasone—ankylosing spondylitis	0.00139	0.00318	CcSEcCtD
Hydroxocobalamin—Pain—Dexamethasone—ankylosing spondylitis	0.00139	0.00318	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00139	0.00317	CcSEcCtD
Hydroxocobalamin—Tachycardia—Prednisone—ankylosing spondylitis	0.00138	0.00316	CcSEcCtD
Hydroxocobalamin—Skin disorder—Prednisone—ankylosing spondylitis	0.00137	0.00314	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00134	0.00308	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00134	0.00306	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00134	0.00306	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—HLA-A—ankylosing spondylitis	0.00134	0.00238	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00132	0.00302	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00132	0.00301	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00132	0.00234	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—B3GNT2—ankylosing spondylitis	0.00131	0.00232	CbGpPWpGaD
Hydroxocobalamin—Malaise—Methotrexate—ankylosing spondylitis	0.00131	0.00299	CcSEcCtD
Hydroxocobalamin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00129	0.00295	CcSEcCtD
Hydroxocobalamin—Urticaria—Betamethasone—ankylosing spondylitis	0.00129	0.00295	CcSEcCtD
Hydroxocobalamin—Dizziness—Prednisolone—ankylosing spondylitis	0.00129	0.00295	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00128	0.00294	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00128	0.00294	CcSEcCtD
Hydroxocobalamin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00127	0.0029	CcSEcCtD
Hydroxocobalamin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00126	0.00289	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Prednisone—ankylosing spondylitis	0.00124	0.00285	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—ankylosing spondylitis	0.00123	0.00282	CcSEcCtD
Hydroxocobalamin—Rash—Prednisolone—ankylosing spondylitis	0.00123	0.00281	CcSEcCtD
Hydroxocobalamin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00123	0.00281	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00122	0.0028	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00122	0.0028	CcSEcCtD
Hydroxocobalamin—Headache—Prednisolone—ankylosing spondylitis	0.00122	0.00279	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—ankylosing spondylitis	0.00122	0.00279	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—TNF—ankylosing spondylitis	0.00122	0.00216	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HLA-A—ankylosing spondylitis	0.00119	0.00212	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HLA-A—ankylosing spondylitis	0.00119	0.00212	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00118	0.00271	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00118	0.00271	CcSEcCtD
Hydroxocobalamin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00118	0.0027	CcSEcCtD
Hydroxocobalamin—Infection—Methotrexate—ankylosing spondylitis	0.00117	0.00269	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00117	0.00267	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00116	0.00265	CcSEcCtD
Hydroxocobalamin—Nausea—Prednisolone—ankylosing spondylitis	0.00116	0.00265	CcSEcCtD
Hydroxocobalamin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00115	0.00263	CcSEcCtD
Hydroxocobalamin—Pruritus—Betamethasone—ankylosing spondylitis	0.00115	0.00263	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00115	0.00263	CcSEcCtD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.00114	0.00202	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HLA-A—ankylosing spondylitis	0.00114	0.00202	CbGpPWpGaD
Hydroxocobalamin—Rash—Triamcinolone—ankylosing spondylitis	0.00113	0.00258	CcSEcCtD
Hydroxocobalamin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00113	0.00258	CcSEcCtD
Hydroxocobalamin—Rash—Methylprednisolone—ankylosing spondylitis	0.00113	0.00258	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00112	0.00258	CcSEcCtD
Hydroxocobalamin—Urticaria—Prednisone—ankylosing spondylitis	0.00112	0.00257	CcSEcCtD
Hydroxocobalamin—Headache—Triamcinolone—ankylosing spondylitis	0.00112	0.00257	CcSEcCtD
Hydroxocobalamin—Headache—Methylprednisolone—ankylosing spondylitis	0.00112	0.00256	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Prednisone—ankylosing spondylitis	0.00112	0.00256	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00111	0.00254	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00111	0.00254	CcSEcCtD
Hydroxocobalamin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00107	0.00246	CcSEcCtD
Hydroxocobalamin—Dizziness—Betamethasone—ankylosing spondylitis	0.00107	0.00246	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.00107	0.0019	CbGpPWpGaD
Hydroxocobalamin—Nausea—Triamcinolone—ankylosing spondylitis	0.00106	0.00243	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—HLA-B—ankylosing spondylitis	0.00106	0.00189	CbGpPWpGaD
Hydroxocobalamin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00106	0.00243	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00105	0.00241	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—HLA-A—ankylosing spondylitis	0.00105	0.00186	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-C—ankylosing spondylitis	0.00105	0.00186	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00104	0.00239	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00104	0.00238	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.00103	0.00183	CbGpPWpGaD
Hydroxocobalamin—Rash—Betamethasone—ankylosing spondylitis	0.00102	0.00234	CcSEcCtD
Hydroxocobalamin—Rash—Dexamethasone—ankylosing spondylitis	0.00102	0.00234	CcSEcCtD
Hydroxocobalamin—Dermatitis—Betamethasone—ankylosing spondylitis	0.00102	0.00234	CcSEcCtD
Hydroxocobalamin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00102	0.00234	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00234	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.00102	0.00181	CbGpPWpGaD
Hydroxocobalamin—Headache—Betamethasone—ankylosing spondylitis	0.00102	0.00233	CcSEcCtD
Hydroxocobalamin—Headache—Dexamethasone—ankylosing spondylitis	0.00102	0.00233	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—ankylosing spondylitis	0.00101	0.00231	CcSEcCtD
Hydroxocobalamin—Pruritus—Prednisone—ankylosing spondylitis	0.001	0.00229	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000974	0.00223	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000968	0.00222	CcSEcCtD
Hydroxocobalamin—Nausea—Dexamethasone—ankylosing spondylitis	0.000965	0.00221	CcSEcCtD
Hydroxocobalamin—Nausea—Betamethasone—ankylosing spondylitis	0.000965	0.00221	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000945	0.00168	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Methotrexate—ankylosing spondylitis	0.000939	0.00215	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—CRP—ankylosing spondylitis	0.000939	0.00167	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Prednisone—ankylosing spondylitis	0.000935	0.00214	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000934	0.00214	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—IL1RN—ankylosing spondylitis	0.000909	0.00161	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—TLR4—ankylosing spondylitis	0.0009	0.0016	CbGpPWpGaD
Hydroxocobalamin—Rash—Prednisone—ankylosing spondylitis	0.000892	0.00204	CcSEcCtD
Hydroxocobalamin—Dermatitis—Prednisone—ankylosing spondylitis	0.000891	0.00204	CcSEcCtD
Hydroxocobalamin—Headache—Prednisone—ankylosing spondylitis	0.000886	0.00203	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000871	0.00199	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—HLA-A—ankylosing spondylitis	0.000862	0.00153	CbGpPWpGaD
Hydroxocobalamin—Nausea—Prednisone—ankylosing spondylitis	0.00084	0.00192	CcSEcCtD
Hydroxocobalamin—Pruritus—Methotrexate—ankylosing spondylitis	0.000836	0.00191	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000809	0.00185	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—CD79A—ankylosing spondylitis	0.000798	0.00142	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Methotrexate—ankylosing spondylitis	0.000782	0.00179	CcSEcCtD
Hydroxocobalamin—Rash—Methotrexate—ankylosing spondylitis	0.000745	0.00171	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000745	0.0017	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—ankylosing spondylitis	0.00074	0.0017	CcSEcCtD
Hydroxocobalamin—MTR—Disease—HLA-A—ankylosing spondylitis	0.000703	0.00125	CbGpPWpGaD
Hydroxocobalamin—Nausea—Methotrexate—ankylosing spondylitis	0.000702	0.00161	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—IL1A—ankylosing spondylitis	0.000654	0.00116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD40LG—ankylosing spondylitis	0.00065	0.00115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000628	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-B—ankylosing spondylitis	0.000619	0.0011	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-A—ankylosing spondylitis	0.000573	0.00102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CRP—ankylosing spondylitis	0.000547	0.000971	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HLA-A—ankylosing spondylitis	0.000529	0.00094	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TLR4—ankylosing spondylitis	0.000524	0.000931	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP3—ankylosing spondylitis	0.000447	0.000794	CbGpPWpGaD
